“What Medicinal Chemists Need to Know about Biology II” returns as an exciting and informative series of lectures aimed at bridging the gap between medicinal chemistry and biology. This series is designed to aid chemists in understanding the features and challenges of the biological aspects of pharmaceutical research and will focus on the in vivo aspects of drug discovery biology, including topics such as:
• Animal disease models
• Biomarkers
• Toxicology in Drug Development
• PK models for new modalities
Experienced speakers from leading pharmaceutical companies will deliver informative lectures with emphasis on Q&A and other interactive elements to maximise learning opportunities.
• Animal disease models
• Biomarkers
• Toxicology in Drug Development
• PK models for new modalities
Experienced speakers from leading pharmaceutical companies will deliver informative lectures with emphasis on Q&A and other interactive elements to maximise learning opportunities.
